Author: perrin - Page 3 - Nanostics Precision Health

38th Annual EAU Congress

perrin2023-03-04T01:38:20+00:00

Date: March 10-13
Venue: In-person, Allianz MiCo, Milano Convention Centre, Milan, Italy

EAU23 is only 1 week away! This is a must-go-to international event dedicated to urology – are you going? Over 4500 abstracts were submitted for EAU23, the third-highest number ever recorded for an Annual EAU Congress.

Hot topics this year include:
Prostate cancer screening and early detection (including imaging), transplant surgery, infections, stones, and major cancers.
Personalized medicine in diagnostics and treatment.
Prostate cancer genomics for practitioners
Men’s health and BPH treatment.
‘Best of EAU’ sessions will be summarised at the end of the congress

SESSION 04

ABSTRACT 0061

38th Annual EAU Congressperrin2023-03-04T01:38:20+00:00

4th Annual AIMSSxGairdner AIHC

perrin2023-03-04T00:12:19+00:00

4th Annual AIMSSxGairdner AI Healthcare Conference

Date: March 10-12
Venue: In-person, and virtual, The Matrix Hotel, Edmonton, Alberta

The AIMSSxGairdner AI-healthcare conference is coming up soon -March 10-12! Make sure to grab your free tickets: bit.ly/4139b6p

CTO Robert Paproski will take part in a panel discussion about AI in the healthcare industry, plus we will have a booth display so come by and say hello!

Nanostics is proud to be a silver-tier sponsor of this event.
#ClarityDX_Prostate #urology #prostatecancer #diagnostics #precisionmedicine

4th Annual AIMSSxGairdner AIHCperrin2023-03-04T00:12:19+00:00

PUA 2023

perrin2023-03-04T00:02:03+00:00

68th Prairie Urological Association Annual Meeting – PUA 2023

Date: March 03-05
Venue: In-person, Lake Louise, Alberta

COO Catalina Vasquez and CCO Colin Coros are in beautiful Lake Louise for the PUA conference

Catalina Vasquez is presenting ClarityDX Prostate: an accurate way to detect clinically significant prostate cancer.

We are proud to be a scientific program session sponsor for this event.
Please reach out to us by DM to chat about our ClarityDX Prostate test.
#ClarityDX_Prostate #urology #prostatecancer #diagnostics #precisionmedicine

PUA 2023perrin2023-03-04T00:02:03+00:00

Molecular Oncology: Building predictive disease models using extracellular vesicle microscale flow cytometry and machine learning

perrin2023-01-09T20:17:59+00:00

We developed the extracellular vesicle machine learning analysis platform (EVMAP) to improve the prediction of diseases such as cancer. The platform combines extracellular vesicle analysis using microscale cytometry with a machine learning approach to generate predictive models. In this work, we utilized EVMAP to generate a blood test to predict high-grade prostate cancer in men that was significantly more accurate than the prostate-specific antigen test. This platform could be applied to many different diseases.

Full Article

Molecular Oncology: Building predictive disease models using extracellular vesicle microscale flow cytometry and machine learningperrin2023-01-09T20:17:59+00:00

Catalina Vasquez and Colin Coros at JPM Week 2023

perrin2023-01-06T00:53:33+00:00

JPM Week 2023

Date: January 9 to 12
Venue: In-person, San Francisco, CA

COO Catalina Vasquez and CCO Colin Coros are kicking off 2023 by going to San Francisco for JPM week, Jan 9 to 12!
Please reach out to us by DM to chat about our ClarityDX Prostate test, a more accurate test for detecting the patient’s risk of aggressive prostate cancer.
For more info about #jpm2023 go to: https://lnkd.in/gkACrmv
#prostatecancer #diagnostics #precisionmedicine

Catalina Vasquez and Colin Coros at JPM Week 2023perrin2023-01-06T00:53:33+00:00

Press Release: Nanostics Announces New Member of Board of Directors

perrin2022-11-17T14:38:46+00:00

Edmonton, Alberta – Nanostics Inc., a precision health diagnostics company, announced today the appointment of Aubrey Rankin to its Board of Directors. Mr. Rankin will join the board of directors at Nanostics replacing Mr. Reg Joseph as one of the independent directors for the company.

“We’re excited to announce Aubrey Rankin’s appointment to Nanostics’ Board of Directors. Aubrey’s vast experience and insights with patient-provider subscription platforms will be invaluable as we launch our lead prostate cancer diagnostic test, ClarityDX Prostate®,” said John Lewis, CEO of Nanostics.

Nanostics sends thanks to outgoing board member Reg Joseph, CEO of Health City, for his service. Reg’s insights into the Healthcare Industry were instrumental in helping Nanostics advance its lead diagnostic product, ClarityDX Prostate® through clinical studies and position it for regulatory approval.

Press Release

Press Release: Nanostics Announces New Member of Board of Directorsperrin2022-11-17T14:38:46+00:00

Desmond Pink at ISEVxTech

perrin2022-11-17T06:10:34+00:00

ISEVxTech Conference

Date: November 16 to 18
Venue: In-person, Waikiki Beach Marriot Resort, Honolulu, HI

CSO Desmond Pink is presenting two posters in Session B on Nov 17th.

1. Qualifying EV Technologies for Regulated and non-Regulated Research

2. Multi-angle flow cytometry illustrates the refractive index complexity

of commonly evaluated biological samples for extracellular vesicle analysis

Desmond Pink at ISEVxTechperrin2022-11-17T06:10:34+00:00

perrin2022-11-22T17:07:22+00:00

CanPath Webinar with Dr. John Lewis

WEBINAR TO BE RESCHEDULED

Webinar: Predicting diseases through machine learning models

Date: Tuesday, November 22. 2022. New date TBD – please check back for updates.
Venue: Online – for more details and to register go to Event Link
Can Machine Learning models predict disease? Dr. John Lewis, Bird Dogs Chair in Translational Oncology at the University of Alberta, and CEO of Nanostics will talk about creating disease prediction models using CanPath questionnaire data, to help us understand the global risk factors of diseases like prostate cancer and how these risk factors differ for different populations.

perrin2022-11-22T17:07:22+00:00

News Release: Recognizing 10 years of philanthropic support for prostate cancer research

perrin2022-10-13T05:02:22+00:00

Two powerhouse researchers in prostate cancer will change the way we treat the disease, thanks to funding from legendary volunteer fundraisers, the Bird Dogs and the Alberta Cancer Foundation.

Working with the Alberta Cancer Foundation and the University of Alberta, the Bird Dogs have enabled a new one-term, five-year chair position to further prostate cancer research — the Bird Dogs Chair in Translational Oncology, a position to be held by researcher Dr. John Lewis. For the last 10 years, Dr. Lewis has held the Frank and Carla Sojonky Chair in Prostate Cancer Research, made possible by a $5 million endowment from the Bird Dogs. Taking over from Dr. Lewis in this position will be surgeon-scientist, Dr. Adam Kinnaird.

News Release

News Release: Recognizing 10 years of philanthropic support for prostate cancer researchperrin2022-10-13T05:02:22+00:00

Amii Artificial Intelligence Virtual Seminar Series

perrin2022-09-02T06:12:20+00:00

What: Nanostics’ CTO Robert Paproski will present “Lessons Learned Developing Predictive Models for Healthcare”

When: September 2, 12-1 pm MT

Go here to access the zoom link and password (scroll to Sept 2) https://sites.google.com/ualberta.ca/ai-seminar/upcoming-seminars

Abstract:
Over the past decade, significant interest has developed for using machine learning in medical devices for assisting in the diagnosis and risk prediction of diseases. Many publications have demonstrated promising preliminary results although the path of deploying a predictive model in the clinic is challenging from a technological and regulatory perspective. This presentation will discuss Nanostics’ work developing ClarityDX Prostate, a medical device which predicts clinically significant prostate cancer, including the challenges of obtaining FDA approval. Training predictive models on large, diverse, clinical datasets is vital for developing trustworthy models although obtaining such datasets can be problematic. Potential solutions for working with large clinical datasets will be discussed.

Amii Artificial Intelligence Virtual Seminar Seriesperrin2022-09-02T06:12:20+00:00

About perrin

Follow Us

Contact Us